• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:病毒感染诱发弥漫性肺泡出血患儿肺损伤和纤维化加重:三例报告

Case Report: virus infection-induced exacerbations of lung injury and fibrosis in children with diffuse alveolar hemorrhage: report of three cases.

作者信息

Wei Qing, Liu Jing, Chen Xun, Li Chunyan, Nong Guangmin, Li Yan

机构信息

Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

出版信息

Front Pediatr. 2025 Aug 21;13:1590800. doi: 10.3389/fped.2025.1590800. eCollection 2025.

DOI:10.3389/fped.2025.1590800
PMID:40918668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12408327/
Abstract

Virus infection is a common cause of lung injury and can result in lung fibrosis in severe cases. Furthermore, it is a significant trigger of disease exacerbation in patients with lung fibrosis. However, nearly all the case reports or case series to date have focused on the adult population rather than the pediatric population. Here, we report three cases of virus infection-induced exacerbations of lung injury and fibrosis in children with diffuse alveolar hemorrhage. To our knowledge, this is one of the first articles to report virus infection-induced lung injury and fibrosis in children.

摘要

病毒感染是肺损伤的常见原因,严重时可导致肺纤维化。此外,它是肺纤维化患者疾病加重的重要诱因。然而,迄今为止,几乎所有的病例报告或病例系列都集中在成人而非儿童群体。在此,我们报告三例病毒感染诱发弥漫性肺泡出血患儿肺损伤和纤维化加重的病例。据我们所知,这是首批报道儿童病毒感染诱发肺损伤和纤维化的文章之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e736/12408327/1e19506764f7/fped-13-1590800-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e736/12408327/d6d4ce0b596a/fped-13-1590800-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e736/12408327/d94a0f16d85c/fped-13-1590800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e736/12408327/1e19506764f7/fped-13-1590800-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e736/12408327/d6d4ce0b596a/fped-13-1590800-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e736/12408327/d94a0f16d85c/fped-13-1590800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e736/12408327/1e19506764f7/fped-13-1590800-g003.jpg

相似文献

1
Case Report: virus infection-induced exacerbations of lung injury and fibrosis in children with diffuse alveolar hemorrhage: report of three cases.病例报告:病毒感染诱发弥漫性肺泡出血患儿肺损伤和纤维化加重:三例报告
Front Pediatr. 2025 Aug 21;13:1590800. doi: 10.3389/fped.2025.1590800. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.常规胸部物理治疗与其他气道清除技术在囊性纤维化中的比较。
Cochrane Database Syst Rev. 2023 May 5;5(5):CD002011. doi: 10.1002/14651858.CD002011.pub3.
4
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.
5
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.用于囊性纤维化患者肺部加重期的静脉用抗生素
Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD009730. doi: 10.1002/14651858.CD009730.pub3.
6
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
7
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
8
Macrolide antibiotics (including azithromycin) for cystic fibrosis.大环内酯类抗生素(包括阿奇霉素)治疗囊性纤维化。
Cochrane Database Syst Rev. 2024 Feb 27;2(2):CD002203. doi: 10.1002/14651858.CD002203.pub5.
9
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.吸入抗生素治疗囊性纤维化肺部加重。
Cochrane Database Syst Rev. 2022 Aug 1;8(8):CD008319. doi: 10.1002/14651858.CD008319.pub4.
10
Nebulised hypertonic saline for cystic fibrosis.雾化高渗盐水用于囊性纤维化
Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD001506. doi: 10.1002/14651858.CD001506.pub4.

本文引用的文献

1
Long-term outcomes of survivors with influenza A H1N1 virus-induced severe pneumonia and ARDS: a single-center prospective cohort study.甲型 H1N1 流感病毒所致重症肺炎和 ARDS 幸存者的长期结局:一项单中心前瞻性队列研究。
Front Cell Infect Microbiol. 2024 Mar 28;14:1378379. doi: 10.3389/fcimb.2024.1378379. eCollection 2024.
2
Alveolar epithelial cells of lung fibrosis patients are susceptible to severe virus-induced injury.肺纤维化患者的肺泡上皮细胞容易受到严重病毒感染的损伤。
Clin Sci (Lond). 2024 Apr 24;138(8):537-554. doi: 10.1042/CS20240220.
3
Update in postinfectious bronchiolitis obliterans.
传染性细支气管炎后闭塞性细支气管炎的最新进展。
Pediatr Pulmonol. 2024 Sep;59(9):2338-2348. doi: 10.1002/ppul.26570. Epub 2023 Jun 28.
4
A case report of pediatric systemic lupus erythematosus with diffuse alveolar hemorrhage following COVID-19 infection: Causation, association, or chance?儿童系统性红斑狼疮 COVID-19 感染后弥漫性肺泡出血 1 例报告:病因、关联还是偶然?
Medicine (Baltimore). 2022 Aug 19;101(33):e30071. doi: 10.1097/MD.0000000000030071.
5
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.SARS-CoV-2 感染引发成纤维细胞增生性巨噬细胞反应和肺纤维化。
Cell. 2021 Dec 22;184(26):6243-6261.e27. doi: 10.1016/j.cell.2021.11.033. Epub 2021 Nov 27.
6
Virus infection induced pulmonary fibrosis.病毒感染导致的肺纤维化。
J Transl Med. 2021 Dec 7;19(1):496. doi: 10.1186/s12967-021-03159-9.
7
Lung transplant to manage end-stage lung disease due to idiopathic pulmonary hemosiderosis: A review of the literature.肺移植治疗特发性肺含铁血黄素沉着症所致终末期肺病:文献复习。
Respir Investig. 2022 Jan;60(1):82-89. doi: 10.1016/j.resinv.2021.06.009. Epub 2021 Jul 24.
8
Diffuse alveolar hemorrhage in children with trisomy 21.唐氏综合征患儿弥漫性肺泡出血。
Pediatr Rheumatol Online J. 2021 Jul 17;19(1):114. doi: 10.1186/s12969-021-00592-4.
9
Six-Month Outcomes of Post-ARDS Pulmonary Fibrosis in Patients With H1N1 Pneumonia.H1N1肺炎患者ARDS后肺纤维化的六个月结局
Front Mol Biosci. 2021 Jun 8;8:640763. doi: 10.3389/fmolb.2021.640763. eCollection 2021.
10
Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by COVID-19: An interventional study.尼达尼布治疗 COVID-19 重症肺炎所致肺纤维化的疗效和安全性:一项干预性研究。
Int J Infect Dis. 2021 Jul;108:454-460. doi: 10.1016/j.ijid.2021.05.055. Epub 2021 May 25.